|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 18.11 USD | -0.44% |
|
+2.55% | +43.73% |
| Market Cap | 5.78B 4.96B 4.63B 4.25B 7.99B 553B 8.12B 54.66B 21.4B 277B 21.72B 21.24B 917B | P/E 2026 * |
40.3x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 8.06B 6.91B 6.45B 5.92B 11.13B 770B 11.32B 76.15B 29.82B 386B 30.25B 29.59B 1,277B | EV / Sales 2026 * |
2.56x | EV / Sales 2027 * | 2.28x |
| Free-Float |
44.29% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Amneal Pharmaceuticals, Inc.
| 1 day | -0.44% | ||
| 1 week | +2.55% | ||
| Current month | -1.15% | ||
| 1 month | +1.46% | ||
| 3 months | +53.34% | ||
| 6 months | +24.04% | ||
| Current year | +43.73% |
| 1 week | 16.87 |  | 18.76 |
| 1 month | 16.77 | | 19.26 |
| Current year | 11.71 | | 19.26 |
| 1 year | 9.2 | | 19.26 |
| 3 years | 3.36 | | 19.26 |
| 5 years | 1.24 | | 19.26 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/13/26 | Sell | Director | -60,000 | 0.0188% | ||
| 8/12/26 | Sell | Head of Human Resources | -146,403 | 0.0458% | ||
| 8/12/26 | Sell | General Counsel | -210,000 | 0.0658% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | +2.55% | +94.11% | +385.52% | 5.78B | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,141B | |
| +0.85% | +4.81% | +53.77% | +58.51% | 659B | |
| +2.72% | +6.92% | +28.99% | +77.15% | 470B | |
| +0.78% | +2.21% | +41.12% | +45.62% | 366B | |
| +0.07% | +2.76% | +24.23% | +41.29% | 302B | |
| -0.53% | +2.47% | +0.18% | +12.40% | 254B | |
| +4.02% | +6.29% | +49.67% | +68.96% | 239B | |
| +0.35% | +0.85% | -12.96% | -52.30% | 207B | |
| +2.90% | +8.63% | +25.11% | +94.52% | 183B | |
| Average | +0.88% | +3.95% | +38.63% | +86.60% | 382.68B | |
| Weighted average by Cap. | +0.56% | +4.31% | +46.90% | +74.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.15B 2.7B 2.52B 2.31B 4.35B 301B 4.42B 29.76B 11.65B 151B 11.82B 11.56B 499B | 3.41B 2.93B 2.73B 2.51B 4.72B 326B 4.8B 32.27B 12.63B 164B 12.82B 12.54B 541B |
| Net income | 149M 128M 119M 109M 206M 14.22B 209M 1.41B 551M 7.13B 559M 547M 23.59B | 295M 253M 236M 217M 407M 28.17B 414M 2.79B 1.09B 14.13B 1.11B 1.08B 46.72B |
| Net Debt | 2.27B 1.95B 1.82B 1.67B 3.14B 217B 3.19B 21.49B 8.41B 109B 8.54B 8.35B 360B | 2B 1.72B 1.6B 1.47B 2.76B 191B 2.81B 18.91B 7.4B 95.9B 7.51B 7.35B 317B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | US$18.11 | -0.44% | 1,469,872 |
| 26-08-18 | US$18.19 | -1.25% | 2,026,546 |
| 26-08-17 | US$18.42 | +1.49% | 1,624,276 |
| 26-08-14 | US$18.15 | +5.10% | 2,006,514 |
| 26-08-13 | US$17.27 | -2.21% | 2,244,114 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Select your edition
All financial news and data tailored to specific country editions
